Medicina
Departamento
St James's University Hospital
Leeds, Reino UnidoPublicaciones en colaboración con investigadores/as de St James's University Hospital (8)
2021
-
COVID-19 in patients with CLL: improved survival outcomes and update on management strategies
Blood, Vol. 138, Núm. 18, pp. 1768-1773
2020
-
COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus
Leukemia, Vol. 34, Núm. 9, pp. 2354-2363
-
Outcomes of COVID-19 in patients with CLL: a multicenter international experience
Blood, Vol. 136, Núm. 10, pp. 1134-1143
-
Venetoclax plus rituximab in relapsed chronic lymphocytic leukemia: 4-year results and evaluation of impact of genomic complexity and gene mutations from the MURANO phase III study
Journal of Clinical Oncology
2018
-
Venetoclax-rituximab in relapsed or refractory chronic lymphocytic leukemia
New England Journal of Medicine, Vol. 378, Núm. 12, pp. 1107-1120
2015
-
Auditing HIV testing rates across Europe: Results from the hides 2 study
PLoS ONE, Vol. 10, Núm. 11
2014
-
Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: Investigation in the QUASAR2 study, systematic review, and meta-analysis
Journal of Clinical Oncology, Vol. 32, Núm. 10, pp. 1031-1039
2006
-
12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplantation recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus
Liver Transplantation, Vol. 12, Núm. 10, pp. 1464-1472